Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment

doi:10.3748/wjg.v23.i25.4538

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6798)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

450

WORD

181

HTML

2901

Figures (1-4)

247

Tables (1-6)

234

Sum=4013

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

985

Download

1800

Sum=2785

Jul 7, 2017 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jul 7, 2017; 23(25): 4538-4547
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4538

Full Size Figure Download Figure

Figure 2 Number of baseline mutations by type of treatment in the interferon-sensitivity-determining region (A) and PKR binding domain (B) of NS5A. PKRBD: PKR binding domain; ISDR: Interferon-sensitivity-determining region.

Citation: Muñoz de Rueda P, Fuentes Rodríguez JM, Quiles Pérez R, Gila Medina A, Martín Álvarez AB, Casado Ruíz J, Ruíz Extremera A, Salmerón J. Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment. World J Gastroenterol 2017; 23(25): 4538-4547
URL: https://www.wjgnet.com/1007-9327/full/v23/i25/4538.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i25.4538